What the company does
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. …
What the weekly tape is saying
LYKALABS closed the latest completed week at 69.60 INR. The 4-week return is 13.0% and the 12-week return is 26.7%. Trend Signal is inactive, Market Dynamics is 1.02. Setup signature: Deep recovery attempt with a 50/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 66.73 INR
- Vs Trend Line
- 4.3%
- Fair Value
- 110.1 INR
- Vs Fair Value
- -36.8%
- 52W High
- 125.5 INR
- 52W Low
- 44.10 INR
- Drawdown
- -44.5%
- Range Position
- 31.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- IN Healthcare
- Sector Rank
- 16 of 161
- Sector Percentile
- 90.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 6 of 12
- Avg 1W
- 2.1%
- Avg 4W
- 10.0%
- Trend Breadth
- 50.0%
- Positive RS
- 50.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.02
- 4W MD Change
- 74.4%
- Relative Strength
- -9.91
- 4W RS Change
- 58.7%
- Expectation
- Negative
- Probability
- 43.44%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 911.5K
- 13W Average
- 330.4K
- 52W Average
- 201.7K
- Vs 13W
- 2.8x
- Vs 52W
- 4.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.5%
- 52W Volatility
- 5.7%
- Upside Weeks
- 18
- Downside Weeks
- 34
- Downside Breadth
- 65.4%
- Avg Gain / Loss
- 4.7% / -3.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- INR
- Market Cap
- 2.1B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 69.60 INR | 9.5% | 66.73 INR | 110.1 INR | 1.02 | -9.91 | 911.5K | Off |
| 5 Jun 2026 | 63.57 INR | 9.0% | 67.35 INR | 110.4 INR | 0.84 | -17.65 | 332.2K | Off |
| 29 May 2026 | 58.30 INR | -5.1% | 68.36 INR | 110.7 INR | 0.82 | -25.89 | 245.2K | Off |
| 22 May 2026 | 61.41 INR | -0.3% | 69.55 INR | 111.0 INR | 0.74 | -23.57 | 57.9K | Off |
| 15 May 2026 | 61.62 INR | -5.8% | 70.67 INR | 111.2 INR | 0.59 | -23.98 | 83.1K | Off |
| 8 May 2026 | 65.38 INR | 9.5% | 71.77 INR | 111.4 INR | 0.41 | -22.04 | 142.2K | Off |
| 1 May 2026 | 59.70 INR | 3.7% | 72.73 INR | 111.6 INR | 0.07 | -28.98 | 96.8K | Off |
| 24 Apr 2026 | 57.58 INR | -3.8% | 74.00 INR | 111.9 INR | -0.22 | -32.02 | 75.7K | Off |
| 17 Apr 2026 | 59.83 INR | 3.1% | 75.24 INR | 112.2 INR | -0.45 | -31.54 | 193.6K | Off |
| 10 Apr 2026 | 58.05 INR | 4.5% | 76.59 INR | 112.5 INR | -0.61 | -33.51 | 362.6K | Off |
| 3 Apr 2026 | 55.53 INR | 19.5% | 77.97 INR | 112.8 INR | -0.73 | -33.41 | 264.7K | Off |
| 27 Mar 2026 | 46.48 INR | -15.4% | 79.43 INR | 113.2 INR | -0.76 | -45.12 | 919.2K | Off |
| 20 Mar 2026 | 54.95 INR | 5.1% | 81.20 INR | 113.6 INR | -0.73 | -36.68 | 609.9K | Off |
| 13 Mar 2026 | 52.29 INR | -13.1% | 82.72 INR | 113.9 INR | -0.77 | -40.52 | 488.6K | Off |